Tag Archives: PRGO

Swiss National Bank Sells 68,800 Shares of Perrigo (PRGO)

Swiss National Bank lessened its stake in shares of Perrigo (NYSE:PRGO) by 14.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 406,662 shares of the company’s stock after selling 68,800 shares during the quarter. Swiss National Bank owned approximately 0.29% of Perrigo worth $33,891,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Crossmark Global Holdings Inc. boosted its stake in Perrigo by 8.3% in the 4th quarter. Crossmark Global Holdings Inc. now owns 7,741 shares of the company’s stock worth $675,000 after buying an additional 595 shares during the last quarter. New Mexico Educational Retirement Board boosted its stake in Perrigo by 5.0% in the 4th quarter. New Mexico Educational Retirement Board now owns 12,700 shares of the company’s stock worth $1,107,000 after buying an additional 600 shares during the last quarter. Norinchukin Bank The boosted its stake in Perrigo by 6.1% in the 4th quarter. Norinchukin Bank The now owns 10,472 shares of the company’s stock worth $913,000 after buying an additional 601 shares during the last quarter. Sentry Investment Management LLC boosted its stake in Perrigo by 9.0% in the 1st quarter. Sentry Investment Management LLC now owns 9,140 shares of the company’s stock worth $762,000 after buying an additional 751 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado boosted its stake in Perrigo by 3.1% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 25,067 shares of the company’s stock worth $2,185,000 after buying an additional 765 shares during the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Get Perrigo alerts:

PRGO has been the topic of a number of research analyst reports. Cantor Fitzgerald set a $107.00 price target on Perrigo and gave the stock a “buy” rating in a research note on Friday, January 19th. Berenberg Bank initiated coverage on Perrigo in a research note on Thursday, February 1st. They issued a “buy” rating and a $117.00 price target on the stock. Oppenheimer reissued a “buy” rating and issued a $98.00 price target on shares of Perrigo in a research note on Tuesday, February 27th. Canaccord Genuity set a $105.00 price target on Perrigo and gave the stock a “buy” rating in a research note on Tuesday, February 27th. Finally, JPMorgan Chase reissued a “neutral” rating and issued a $83.00 price target (up from $82.00) on shares of Perrigo in a research note on Monday, March 5th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and nine have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $93.06.

Shares of NYSE:PRGO opened at $75.86 on Friday. The stock has a market cap of $10.48 billion, a P/E ratio of 14.69, a P/E/G ratio of 1.78 and a beta of 0.77. The company has a current ratio of 2.08, a quick ratio of 1.48 and a debt-to-equity ratio of 0.53. Perrigo has a one year low of $75.66 and a one year high of $76.20.

Perrigo (NYSE:PRGO) last announced its earnings results on Tuesday, May 8th. The company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.14 by $0.12. The business had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.21 billion. Perrigo had a return on equity of 11.93% and a net margin of 2.59%. The company’s revenue was up 1.9% on a year-over-year basis. During the same period last year, the business posted $1.05 EPS. equities analysts forecast that Perrigo will post 5.25 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 19th. Investors of record on Friday, June 1st will be issued a dividend of $0.19 per share. The ex-dividend date of this dividend is Thursday, May 31st. This represents a $0.76 annualized dividend and a dividend yield of 1.00%. Perrigo’s payout ratio is currently 15.42%.

In related news, Director Jeffrey C. Smith bought 250,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 15th. The shares were acquired at an average cost of $75.21 per share, for a total transaction of $18,802,500.00. Following the acquisition, the director now owns 528 shares in the company, valued at approximately $39,710.88. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Uwe Roehrhoff bought 7,500 shares of the company’s stock in a transaction that occurred on Monday, March 5th. The shares were bought at an average price of $81.85 per share, for a total transaction of $613,875.00. Following the completion of the acquisition, the chief executive officer now owns 4,900 shares in the company, valued at approximately $401,065. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 307,500 shares of company stock worth $23,210,875. Company insiders own 6.90% of the company’s stock.

About Perrigo

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Wells Fargo Lowers Perrigo (PRGO) Price Target to $84.00

Perrigo (NYSE:PRGO) had its price target cut by Wells Fargo from $90.00 to $84.00 in a research report released on Monday, Marketbeat Ratings reports. They currently have a market perform rating on the stock.

PRGO has been the subject of several other research reports. Canaccord Genuity set a $105.00 price objective on Perrigo and gave the stock a buy rating in a report on Monday, March 26th. Oppenheimer set a $98.00 price objective on Perrigo and gave the stock a buy rating in a report on Monday, March 5th. Cantor Fitzgerald set a $107.00 price objective on Perrigo and gave the stock a buy rating in a report on Friday, January 19th. Finally, ValuEngine lowered Perrigo from a hold rating to a sell rating in a research note on Wednesday, May 9th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and nine have issued a buy rating to the stock. Perrigo presently has an average rating of Hold and an average target price of $93.06.

Get Perrigo alerts:

Shares of NYSE PRGO opened at $75.86 on Monday. Perrigo has a 12 month low of $75.66 and a 12 month high of $76.20. The company has a quick ratio of 1.48, a current ratio of 2.08 and a debt-to-equity ratio of 0.53. The stock has a market cap of $10.46 billion, a PE ratio of 15.39, a price-to-earnings-growth ratio of 1.77 and a beta of 0.77.

Perrigo (NYSE:PRGO) last issued its quarterly earnings data on Tuesday, May 8th. The company reported $1.26 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.14 by $0.12. Perrigo had a return on equity of 11.93% and a net margin of 2.59%. The company had revenue of $1.22 billion during the quarter, compared to analyst estimates of $1.21 billion. During the same quarter in the previous year, the firm earned $1.05 earnings per share. Perrigo’s revenue was up 1.9% on a year-over-year basis. sell-side analysts anticipate that Perrigo will post 5.25 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 19th. Shareholders of record on Friday, June 1st will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 1.00%. The ex-dividend date of this dividend is Thursday, May 31st. Perrigo’s dividend payout ratio is currently 15.42%.

In related news, CEO Uwe Roehrhoff acquired 7,500 shares of the stock in a transaction on Monday, March 5th. The stock was purchased at an average price of $81.85 per share, for a total transaction of $613,875.00. Following the completion of the transaction, the chief executive officer now owns 4,900 shares of the company’s stock, valued at approximately $401,065. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Jeffrey C. Smith acquired 50,000 shares of the stock in a transaction on Thursday, May 17th. The stock was bought at an average price of $75.89 per share, with a total value of $3,794,500.00. Following the transaction, the director now directly owns 528 shares of the company’s stock, valued at approximately $40,069.92. The disclosure for this purchase can be found here. Insiders acquired 307,500 shares of company stock valued at $23,210,875 in the last quarter. Corporate insiders own 6.90% of the company’s stock.

A number of hedge funds have recently made changes to their positions in PRGO. Nisa Investment Advisors LLC lifted its position in Perrigo by 19.4% in the fourth quarter. Nisa Investment Advisors LLC now owns 12,300 shares of the company’s stock valued at $1,072,000 after purchasing an additional 2,000 shares during the last quarter. Bank of Montreal Can lifted its position in Perrigo by 140.1% in the fourth quarter. Bank of Montreal Can now owns 225,504 shares of the company’s stock valued at $19,655,000 after purchasing an additional 131,570 shares during the last quarter. E&G Advisors LP bought a new stake in Perrigo in the fourth quarter valued at approximately $288,000. Schwab Charles Investment Management Inc. lifted its position in Perrigo by 9.6% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 506,255 shares of the company’s stock valued at $44,126,000 after purchasing an additional 44,203 shares during the last quarter. Finally, Oakbrook Investments LLC bought a new stake in Perrigo in the fourth quarter valued at approximately $436,000. Hedge funds and other institutional investors own 79.52% of the company’s stock.

About Perrigo

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

Analyst Recommendations for Perrigo (NYSE:PRGO)

Cantor Fitzgerald Analysts Give Perrigo (PRGO) a $107.00 Price Target

Cantor Fitzgerald set a $107.00 price target on Perrigo (NYSE:PRGO) in a research note released on Monday. The brokerage currently has a buy rating on the stock.

A number of other analysts have also recently issued reports on the company. Canaccord Genuity set a $105.00 target price on Perrigo and gave the stock a buy rating in a research note on Monday, April 16th. Wells Fargo lowered their target price on Perrigo from $90.00 to $84.00 and set a market perform rating for the company in a research note on Monday. Berenberg Bank initiated coverage on Perrigo in a research note on Thursday, February 1st. They set a buy rating and a $117.00 target price for the company. JPMorgan Chase reissued a neutral rating and set a $83.00 target price (up from $82.00) on shares of Perrigo in a research note on Monday, March 5th. Finally, ValuEngine cut Perrigo from a hold rating to a sell rating in a research note on Wednesday, May 9th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and nine have issued a buy rating to the company. Perrigo currently has a consensus rating of Hold and an average price target of $93.06.

Get Perrigo alerts:

Shares of PRGO stock opened at $75.68 on Monday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.08 and a quick ratio of 1.48. The stock has a market capitalization of $10.38 billion, a PE ratio of 15.35, a P/E/G ratio of 1.85 and a beta of 0.77. Perrigo has a one year low of $75.66 and a one year high of $76.20.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Tuesday, May 8th. The company reported $1.26 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.12. The company had revenue of $1.22 billion during the quarter, compared to analysts’ expectations of $1.21 billion. Perrigo had a return on equity of 11.93% and a net margin of 2.59%. Perrigo’s revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.05 EPS. sell-side analysts expect that Perrigo will post 5.25 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 19th. Shareholders of record on Friday, June 1st will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 1.00%. The ex-dividend date is Thursday, May 31st. Perrigo’s dividend payout ratio (DPR) is currently 15.42%.

In other news, CEO Uwe Roehrhoff purchased 7,500 shares of Perrigo stock in a transaction on Monday, March 5th. The stock was purchased at an average price of $81.85 per share, with a total value of $613,875.00. Following the transaction, the chief executive officer now directly owns 4,900 shares in the company, valued at approximately $401,065. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 6.90% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in PRGO. Dupont Capital Management Corp acquired a new position in Perrigo during the 4th quarter worth approximately $104,000. Twin Tree Management LP boosted its holdings in shares of Perrigo by 271.0% in the 1st quarter. Twin Tree Management LP now owns 2,223 shares of the company’s stock valued at $185,000 after buying an additional 3,523 shares during the last quarter. Allianz Asset Management GmbH acquired a new stake in shares of Perrigo in the 1st quarter valued at approximately $205,000. Dean Capital Investments Management LLC acquired a new stake in shares of Perrigo in the 1st quarter valued at approximately $209,000. Finally, ARP Americas LP acquired a new stake in shares of Perrigo in the 4th quarter valued at approximately $212,000. 79.52% of the stock is owned by hedge funds and other institutional investors.

About Perrigo

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

Analyst Recommendations for Perrigo (NYSE:PRGO)

Perrigo Target of Unusually Large Options Trading (PRGO)

Perrigo (NYSE:PRGO) was the target of unusually large options trading activity on Monday. Traders purchased 3,137 put options on the stock. This represents an increase of approximately 764% compared to the average volume of 363 put options.

In other news, CEO Uwe Roehrhoff purchased 7,500 shares of Perrigo stock in a transaction that occurred on Monday, March 5th. The shares were acquired at an average price of $81.85 per share, for a total transaction of $613,875.00. Following the transaction, the chief executive officer now owns 4,900 shares of the company’s stock, valued at approximately $401,065. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 6.90% of the company’s stock.

Get Perrigo alerts:

Hedge funds have recently added to or reduced their stakes in the company. Dupont Capital Management Corp bought a new position in shares of Perrigo during the fourth quarter valued at $104,000. Twin Tree Management LP raised its stake in shares of Perrigo by 271.0% during the first quarter. Twin Tree Management LP now owns 2,223 shares of the company’s stock valued at $185,000 after acquiring an additional 3,523 shares during the last quarter. ARP Americas LP bought a new position in shares of Perrigo during the fourth quarter valued at $212,000. Quantitative Systematic Strategies LLC bought a new position in shares of Perrigo during the fourth quarter valued at $213,000. Finally, Investors Research Corp bought a new position in shares of Perrigo during the fourth quarter valued at $214,000. 79.52% of the stock is owned by hedge funds and other institutional investors.

PRGO has been the topic of several analyst reports. Canaccord Genuity set a $105.00 price target on shares of Perrigo and gave the stock a “buy” rating in a research report on Monday, April 16th. Cantor Fitzgerald set a $107.00 price target on shares of Perrigo and gave the stock a “buy” rating in a research report on Tuesday, May 8th. Wells Fargo set a $84.00 price target on shares of Perrigo and gave the stock a “market perform” rating in a research report on Monday. Berenberg Bank initiated coverage on shares of Perrigo in a research report on Thursday, February 1st. They set a “buy” rating and a $117.00 price target on the stock. Finally, JPMorgan Chase reiterated a “neutral” rating and set a $83.00 price target (up previously from $82.00) on shares of Perrigo in a research report on Monday, March 5th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and nine have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $93.06.

Shares of Perrigo opened at $74.94 on Tuesday, MarketBeat.com reports. Perrigo has a fifty-two week low of $71.37 and a fifty-two week high of $75.36. The company has a current ratio of 2.08, a quick ratio of 1.48 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $10.73 billion, a price-to-earnings ratio of 15.05, a P/E/G ratio of 1.91 and a beta of 0.77.

Perrigo (NYSE:PRGO) last issued its earnings results on Tuesday, May 8th. The company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.14 by $0.12. Perrigo had a net margin of 2.59% and a return on equity of 11.93%. The firm had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.21 billion. During the same quarter last year, the business posted $1.05 earnings per share. The company’s quarterly revenue was up 1.9% on a year-over-year basis. equities analysts anticipate that Perrigo will post 5.27 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 19th. Shareholders of record on Friday, June 1st will be given a $0.19 dividend. The ex-dividend date of this dividend is Thursday, May 31st. This represents a $0.76 dividend on an annualized basis and a yield of 1.01%. Perrigo’s dividend payout ratio is currently 15.42%.

Perrigo Company Profile

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.